Heather J. Bax

St. John's Institute Of Dermatology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Basophils in Immunity: Activation Pathways, Roles in Allergy and AllergoOncology and Application of the Basophil Activation Test.

Basophils in Immunity: Activation Pathways, Roles in Allergy and AllergoOncology and Application of the Basophil Activation Test.

Journal: Allergy

Published: May 08, 2026

AllergoOncology: Emerging Translational and Clinical Significance of Basophils and Mast Cells in Cancer.

AllergoOncology: Emerging Translational and Clinical Significance of Basophils and Mast Cells in Cancer.

Journal: Clinical and translational allergy

Published: January 05, 2026

Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability.

Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability.

Journal: mAbs

Published: May 28, 2025

Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality.

Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality.

Journal: mAbs

Published: May 16, 2025

Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review.

Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review.

Journal: Allergy

Published: March 11, 2025

Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper.

Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper.

Journal: Allergy

Published: March 01, 2025

Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production.

Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production.

Journal: mAbs

Published: January 20, 2025

Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors.

Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors.

Journal: Journal for immunotherapy of cancer

Published: January 15, 2025

An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities.

An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 08, 2024

Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Journal: Cancers

Published: September 02, 2024

Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.

Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.

Journal: Allergy

Published: August 14, 2024

Granulocytes and mast cells in AllergoOncology-Bridging allergy to cancer: An EAACI position paper.

Granulocytes and mast cells in AllergoOncology-Bridging allergy to cancer: An EAACI position paper.

Journal: Allergy

Published: April 25, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026